Last Friday, Prof. Dr Rainer Klump, the President of the University of Luxembourg, Dr Marc Schiltz, the Secretary General of the Fonds National de la Recherche (FNR) and Prof. Dr Rudi Balling, the Director of the LCSB, volunteered as control subjects (i.e. people not affected by Parkinson's disease) in the Luxembourg Parkinson Study, within the National Centre for Excellence in Research (NCER-PD).
Beginning of January 2017, renowned neuropathologist Professor Dr. Michel Mittelbronn joined the Laboratoire national de santé (LNS) in a joint appointment with the Luxembourg Institute of Health (LIH) and the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg.
A clinical study at the Centre Hospitalier de Luxembourg (CHL) is testing new combined deep brain simulation (DBS) to counteract gait blocks.
Page 9 of 15